Augmentation of Cellular Immune Function during the Early Phase of Zidovudine Treatment of AIDS Pati...
Augmentation of Cellular Immune Function during the Early Phase of Zidovudine Treatment of AIDS Patients
About this item
Full title
Author / Creator
Publisher
Chicago, IL: The University of Chicago Press
Journal title
Language
English
Formats
Publication information
Publisher
Chicago, IL: The University of Chicago Press
Subjects
More information
Scope and Contents
Contents
Twenty-five patients with AIDS in AIDS Clinical Trials Group Protocol 002 were treated with either low or high dosages ofzidovudine. This resulted in moderate, transient increases by 10 and 20 weeks in lymphocyte blastogenesis and interferon-γ (IFN-γ) production in vitro in response to phytohemagglutinin with and without recombinant interleukin-2....
Alternative Titles
Full title
Augmentation of Cellular Immune Function during the Early Phase of Zidovudine Treatment of AIDS Patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_72103609
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_72103609
Other Identifiers
ISSN
0022-1899
E-ISSN
1537-6613
DOI
10.1093/infdis/164.4.638
